Effects of Curcuma longa (turmeric) as an adjunct to antihypertensive drugs among stage 1 and 2 hypertensive individuals: A clinical study
by Forest Raga January 16, 2021
The present study was carried out to investigate the efficacy and safety of Curcuma longa (turmeric) as an adjunct to antihypertensive drugs among stage 1 and 2 hypertensive individualsAims & objectives
To compare the clinical efficacy of Curcuma longa (turmeric) as an adjunct to
antihypertensive drugs among stage 1 and 2 hypertensive individuals
Turmeric has been shown to have the potential to alleviate the disease burden of
hypertension through its atherosclerotic-protective effect. This study was done to determine the efficacy and safety of turmeric as an adjunct to antihypertensive medications in the management of stage 1 and 2 hypertension
Using a randomized double-blind placebo-controlled clinical trial, subjects were assigned to
receive turmeric capsules or placebo for four weeks. Intra- and intergroup analysis of a significant decrease in the blood pressure was determined after treatment. A repeated measure ANOVA was used to determine the significant differences in the BP readings. Side effects of taking turmeric capsules were determined.
Systolic blood pressure in the turmeric group started to decline after the first week of
treatment, but the decrement became statistically significant starting only in the third through the fourth week. There was a statistically significant decrease in the mean systolic blood pressure for those taking turmeric. Treatment success was significantly higher among the turmeric group.
Turmeric may be an effective adjunct to antihypertensive drugs in controlling and
maintaining systolic blood pressure.
If you want to include turmeric in your daily schedule click here.
Subscribe to learn more.
To read the detailed research experiment, please click here.